AnaptysBio, Inc. ($ANAB)
Filing Information
| Accession Number | 0001239648-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 6, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
61,029
Total Value
$439,199.76
P&L
+inf% (+$2,513,309.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF LEGAL OFFICER | Common Stock | โ | Jan 6, 2026 | Exercise/Conversion | 5,545 | โ | โ | 18,796 | Direct | โ | View Details | |
CHIEF LEGAL OFFICER | Common Stock | โ | Jan 7, 2026 | Sale | 2,017 | $45.11 | $90,986.87 | 16,779 | Direct | โ | View Details | |
CHIEF LEGAL OFFICER | Common Stock | โ | Jan 7, 2026 | Sale | 5,281 | $45.38 | $239,672.38 | 11,498 | Direct | โ | View Details | |
CHIEF LEGAL OFFICER | Common Stock | โ | Jan 7, 2026 | Sale | 1,841 | $46.13 | $84,925.51 | 9,657 | Direct | โ | View Details | |
CHIEF LEGAL OFFICER | Common Stock | โ | Jan 7, 2026 | Sale | 500 | $47.23 | $23,615.00 | 9,157 | Direct | โ | View Details | |
CHIEF LEGAL OFFICER | Restricted Stock Unit | Derivative | Jan 6, 2026 | Exercise/Conversion | 5,545 | $0.00 | $0.00 | 5,545 | Direct | โ | View Details | |
CHIEF LEGAL OFFICER | Restricted Stock Unit | Derivative | Jan 6, 2026 | Grant/Award | 17,100 | $0.00 | $0.00 | 17,100 | Direct | โ | View Details | |
CHIEF LEGAL OFFICER | Stock Option (right to buy) | Derivative | Jan 6, 2026 | Grant/Award | 23,200 | $0.00 | $0.00 | 23,200 | Direct | โ | View Details |